We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
According to Chinese state media, two Chinese companies have agreed
to set up a new manufacturing plant in Pakistan with local conglomerate Royal
Group. Under the agreement, SPGC Sine Pharmaceutical Laboratories and Orient
International Holding are to invest US$5mn on the new facility, to be built
in Karachi.
Indian drugmakers are increasingly shifting manufacturing operations
to low-tariff states elsewhere in the country, as new price-related excise costs
begin to discourage export production in wealthier regions.
A visiting delegation of Iranian officials and representatives of pharmaceuticals
interests has prompted local reports that drugmakers from that country are to
establish animal vaccines manufacturing plants in Zimbabwe.
Iceland-based generic drugmaker Actavis has announced plans to acquire
Indian clinical trials specialist Lotus Laboratories for roughly EUR20mn (US$25.52mn).
German drug major Schering AG has reported a 1% decline in fourth-quarter
revenue to EUR1.26bn (US$1.62bn), although pretax profit increased by 13% to
EUR161mn (US$205.79mn).
Australian authorities have outlined measures to establish an independent
review mechanism for drug approvals following the country's new free trade agreement
with the US.